Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Heffner

Showing results (871-880 of 1,030) with videos related to

Pageof 103
Sort By:
Cancer|August 8, 2013
Epsilon aminocaproic acid prevents bleeding in severely thrombocytopenic patients with hematological malignanciesAna G Antun, Shannon Gleason, Martha Arellano, et al.
Surgery|June 25, 2014
Oncolytic immunotherapy using recombinant vaccinia virus GLV-1h68 kills sorafenib-resistant hepatocellular carcinoma efficientlyJustin W Ady, Jacqueline Heffner, Kelly Mojica, et al.
Pharmaceutical Research|March 1, 1997
Pharmacokinetics and pharmacodynamics of an investigational antipsychotic agent, CI-1007, in rats and monkeysM R Feng, A E Corbin, Y Wang, et al.
Blood Cancer Journal|January 6, 2019
Combining carfilzomib and panobinostat to treat relapsed/refractory multiple myeloma: results of a Multiple Myeloma Research Consortium Phase I StudyJonathan L Kaufman, Roberto Mina, Andrzej J Jakubowiak, et al.
Critical Care Medicine|July 16, 2019
Predictive Accuracy of Quick Sequential Organ Failure Assessment for Hospital Mortality Decreases With Increasing Comorbidity Burden Among Patients Admitted for Suspected InfectionStephanie Parks Taylor, Andrew McWilliams, Brice T Taylor, et al.
Clinical Lymphoma, Myeloma & Leukemia|October 8, 2013
Vinorelbine, paclitaxel, etoposide, cisplatin, and cytarabine (VTEPA) is an effective second salvage therapy for relapsed/refractory Hodgkin lymphomaRajni Sinha, Pareen J Shenoy, Nassoma King, et al.
Cancer|April 27, 2012
A phase 1 dose escalation study of bortezomib combined with rituximab, cyclophosphamide, doxorubicin, modified vincristine, and prednisone for untreated follicular lymphoma and other low-grade B-cell lymphomasRajni Sinha, Jonathan L Kaufman, Hanna Jean Khoury, et al.
Leukemia & Lymphoma|October 19, 2013
Sensitivity and specificity of cerebrospinal fluid flow cytometry for the diagnosis of leukemic meningitis in acute lymphoblastic leukemia/lymphomaZahi Mitri, Momin T Siddiqui, Fuad El Rassi, et al.
Bioorganic & Medicinal Chemistry Letters|January 5, 1999
Isoindolinone enantiomers having affinity for the dopamine D4 receptorT R Belliotti, W A Brink, S R Kesten, et al.
Clinical Lymphoma, Myeloma & Leukemia|August 22, 2020
Phase 1 Trial Evaluating Vorinostat Plus Bortezomib, Lenalidomide, and Dexamethasone in Patients With Newly Diagnosed Multiple MyelomaJonathan L Kaufman, Roberto Mina, Jatin J Shah, et al.
Pageof 103

Showing results (871-880 of 1,030) with videos related to

Sort By:
Pageof 103
Cancer|August 8, 2013
Epsilon aminocaproic acid prevents bleeding in severely thrombocytopenic patients with hematological malignanciesAna G Antun, Shannon Gleason, Martha Arellano, et al.
Surgery|June 25, 2014
Oncolytic immunotherapy using recombinant vaccinia virus GLV-1h68 kills sorafenib-resistant hepatocellular carcinoma efficientlyJustin W Ady, Jacqueline Heffner, Kelly Mojica, et al.
Pharmaceutical Research|March 1, 1997
Pharmacokinetics and pharmacodynamics of an investigational antipsychotic agent, CI-1007, in rats and monkeysM R Feng, A E Corbin, Y Wang, et al.
Blood Cancer Journal|January 6, 2019
Combining carfilzomib and panobinostat to treat relapsed/refractory multiple myeloma: results of a Multiple Myeloma Research Consortium Phase I StudyJonathan L Kaufman, Roberto Mina, Andrzej J Jakubowiak, et al.
Critical Care Medicine|July 16, 2019
Predictive Accuracy of Quick Sequential Organ Failure Assessment for Hospital Mortality Decreases With Increasing Comorbidity Burden Among Patients Admitted for Suspected InfectionStephanie Parks Taylor, Andrew McWilliams, Brice T Taylor, et al.
Clinical Lymphoma, Myeloma & Leukemia|October 8, 2013
Vinorelbine, paclitaxel, etoposide, cisplatin, and cytarabine (VTEPA) is an effective second salvage therapy for relapsed/refractory Hodgkin lymphomaRajni Sinha, Pareen J Shenoy, Nassoma King, et al.
Cancer|April 27, 2012
A phase 1 dose escalation study of bortezomib combined with rituximab, cyclophosphamide, doxorubicin, modified vincristine, and prednisone for untreated follicular lymphoma and other low-grade B-cell lymphomasRajni Sinha, Jonathan L Kaufman, Hanna Jean Khoury, et al.
Leukemia & Lymphoma|October 19, 2013
Sensitivity and specificity of cerebrospinal fluid flow cytometry for the diagnosis of leukemic meningitis in acute lymphoblastic leukemia/lymphomaZahi Mitri, Momin T Siddiqui, Fuad El Rassi, et al.
Bioorganic & Medicinal Chemistry Letters|January 5, 1999
Isoindolinone enantiomers having affinity for the dopamine D4 receptorT R Belliotti, W A Brink, S R Kesten, et al.
Clinical Lymphoma, Myeloma & Leukemia|August 22, 2020
Phase 1 Trial Evaluating Vorinostat Plus Bortezomib, Lenalidomide, and Dexamethasone in Patients With Newly Diagnosed Multiple MyelomaJonathan L Kaufman, Roberto Mina, Jatin J Shah, et al.
Pageof 103